Skip to main content

Table 2 miRNAs as prognostic factors and the associated targets and survival status in pancreatic cancer

From: MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators

miRNAExpression in Pancreatic Cancer compared to normal tissueSurvival StatusTargetsReference
-10bUpregulatedPoor SurvivalTIP30[94, 95]
−21UpregulatedWorse SurvivalPTEN, PDCD4, IL-6R,CDK6[85,86,87]
-34aUpregulatedBetter SurvivalNOTCH, BCL2, CDK6[96,97,98]
−155UpregulatedPoor SurvivalTP53INP[99, 100]
-let-7 FamilyDownregulatedPoor SurvivalKRAS, HRAS, TRIM71[101, 102]
−200 FamilyDownregulatedBetter SurvivalE-cadherin, ZEB[91, 96, 103]
−216DownregulatedPoor SurvivalROCK1[104, 105]